NYSE:AIM

Aim Immunotech Stock News

Healthcare > Biotechnology

Buy AIM

*Your capital is at risk

$0.732

-0.0947 (-11.46%)

At Close: Jun 03, 2026

NRZ, TLRY among premarket gainers

01:16pm, Thursday, 26'th Mar 2020

Granite Point Mortgage Trust (NYSE:GPMT) +104% on suspending Q1 dividend in move to conserve cash.MFA Financial (NYSE:MFA) +75% on cancelling dividend.Wanda Sports Group Company (NASDAQ:WSG) +55% a

AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic

12:00pm, Thursday, 26'th Mar 2020

OCALA, FL / ACCESSWIRE / March 26, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that it is actively seeking investigators and sites for clinical testing of Ampligen as a protective prophy

SLS, APRN among premarket gainers

01:23pm, Wednesday, 18'th Mar 2020

Biomerica (NASDAQ:BMRA) +133% on advancement of rapid coronavirus test.IMV (NASDAQ:IMV) +55% on coronavirus vaccine plan.Vaxart (NASDAQ:VXRT) +46% on coronavirus vaccine deal.Blue Apron Holdings (N

Analyzing Editas Medicine (NASDAQ:EDIT) & AIM ImmunoTech (NASDAQ:AIM)

07:42am, Wednesday, 18'th Mar 2020

AIM ImmunoTech (NYSE:AIM) and Editas Medicine (NASDAQ:EDIT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of thei

The Coronavirus Pandemic Has Revealed Some Micro-Cap Opportunities

09:06pm, Friday, 13'th Mar 2020

The Coronavirus Pandemic Has Revealed Some Micro-Cap Opportunities, Stocks: CODX,HOLX,AIM,NNVC,GOOG,GOOGL,FB,LAKE,TBLT,LOW,HD,, release date:Mar 13, 2020

INO, MNK among premarket gainers

01:16pm, Thursday, 12'th Mar 2020

Predictive Oncology (NASDAQ:POAI) +50% on launching a new AI platform for vaccine and drug development targeting coronaviruses and acute respiratory syndromes.Chembio Diagnostics (NASDAQ:CEMI) +42%

Mid-Afternoon Market Update: Dow Tumbles 8%; AIM ImmunoTech Shares Spikes Higher

06:41pm, Monday, 09'th Mar 2020

Toward the end of trading Monday, the Dow traded down 8% to 23794.55 while the NASDAQ fell 6.95% to 7,979.78. The S&P also fell, dropping 7.71% to 2,743.27. Coronavirus cases...

Mid-Day Market Update: Dow Falls 1400 Points; Matador Resources Shares Plunge

04:25pm, Monday, 09'th Mar 2020

Midway through trading Monday, the Dow traded down 5.43% to 24,461 while the NASDAQ fell 4.35% to 8,202.44. The S&P also fell, dropping 5.03% to 2822.74. Coronavirus cases...

101 Stocks Moving In Monday's Mid-Day Session

04:00pm, Monday, 09'th Mar 2020

Gainers Spherix Incorporated (NASDAQ: SPEX) shares jumped 139% to $3.92 after jumping 131% on Friday. AIM ImmunoTech Inc. (NYSE: AIM) shares jumped 63.1% to $3.43 amid the...

AIM ImmunoTech’s Drug Ampligen to Be Tested by Japan’s National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human Infectious Disease COVID-19

10:30am, Monday, 09'th Mar 2020

OCALA, FL / ACCESSWIRE / March 9, 2020 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by